Ziwig: winner of the Prix Galien 2022
for its innovation Ziwig Endotest®
Healthcare professional: be notified when Ziwig Endotest® is available
Ziwig Endotest®
The saliva test* available to healthcare professionals for the diagnosis of endometriosis:
a breakthrough for women’s health!
Ziwig supports
women and health professionals in the fight against endometriosis.
The detection of the disease is at the core of the national strategy to fight endometriosis put in place in January 2022 by the President of the Republic, Emmanuel Macron.
Ziwig: a global approach of the endometriosis to
improve the quality of life and the care of the patients.
Ziwig’s other solutions to improve quality of life and patient care. In parallel of Ziwig Endotest®, Ziwig has developed digital solutions to facilitate the care path and to live better with endometriosis, in complete autonomy. Discover the other solutions of Ziwig:
New !
Endocoach
An individualized coaching application to improve quality of life
Endoconnect
Your best ally to start, track and evolve your healthcare journey over time
The disruptive innovations behind Ziwig's solutions
The alliance of science and cutting-edge technologies at the service of tomorrow’s health
This page is exclusively intended for healthcare professionals.
* Ziwig Endotest® is an in vitro diagnostic device reserved exclusively for professional use for the diagnosis of endometriosis on salivary samples.
Ziwig Endotest® is an innovative diagnostic method based on the analysis of salivary miRNAs and the identification of phenotypic profiles characteristic of endometriosis identified by NGS (Next Generation Sequencing) method and modeled by AI.
Read carefully the information provided with Ziwig Endotest®. Manufacturer: Ziwig. Update: 06/2022
1- Machine learning algorithms as new screening approach for patients with endometriosis.
Bendifallah S & al. Sci Rep. 2022 Jan 12;12(1):639. doi: 10.1038/s41598-021-04637-2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755739/pdf/41598_2021_Article_4637.pdf
2 – Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression.
Dabi Y & al. Diagnostics (Basel). 2022 Jan 12;12(1):175. doi: 10.3390/diagnostics12010175.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774370/pdf/diagnostics-12-00175.pdf
3 – Salivary MicroRNA Signature for Diagnosis of Endometriosis.
Bendifallah & al. J Clin Med. 2022 Jan 26;11(3):612. doi: 10.3390/jcm11030612.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836532/pdf/jcm-11-00612.pdf
4 – MicroRNome analysis generates a blood-based signature for endometriosis.
Bendifallah S & al. Sci Rep. 2022 Mar 8;12(1):4051. doi: 10.1038/s41598-022-07771-7.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902281/pdf/41598_2022_Article_7771.pdf
5 – Endometriosis Associated-miRNome Analysis of Blood Samples: A Prospective Study
Bendifallah S & al. Diagnostics. 2022; 12(5):1150.
https://doi.org/10.3390/diagnostics12051150
6 – A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis.
Bendifallah S & al. Int. J. Mol. 2022, 23, 8045.
https://doi.org/10.3390/ijms23148045
Find all our scientific publications here.
